Synlett 2003(7): 1031-1033
DOI: 10.1055/s-2003-39317
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Azacycles Based on Iridium-Catalyzed Sequential Allylic Amination

Hideto Miyabe, Kazumasa Yoshida, Yusuke Kobayashi, Akira Matsumura, Yoshiji Takemoto*
Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
e-Mail: takemoto@pharm.kyoto-u.ac.jp;
Further Information

Publication History

Received 13 March 2003
Publication Date:
20 May 2003 (online)

Abstract

The iridium-catalyzed sequential allylic amination of substrates having two allylic carbonate moieties proceeded smoothly, providing the novel method for synthesis of azacycles.

8

Preparation of 4a and 5-7: To a solution of a corres-ponding dialdehyde (1 equiv) in THF was added vinyl-magnesium bromide (2.6 equiv) under an argon atmosphere at 0 °C. After being stirred at same tempareture for 3 h, the reaction mixture was quenched with 1 M HCl, and then extracted with Et2O. The organic phase was washed with H2O, aq NaHCO3 and brine, dried over MgSO4, and concentrated at reduced pressure. Purification of the residue by flash chromatography (hexane:EtOAc = 3:1) afforded diol. To a solution of diol (1 equiv) in pyridine or pyridine-CH2Cl2 were added DMAP (0.06 equiv) and MeOCOCl (5 equiv) under an argon atmosphere at 0 °C. After being stirred at same tempareture for 1-24 h, the reaction mixture was diluted with H2O, and then extracted with Et2O. The organic phase was washed with H2O and brine, dried over MgSO4, and concentrated at reduced pressure. Purification of the residue by flash chromatography (hexane:EtOAc = 10:1) afforded 4a or 5-7.

10

Representative Experimental Procedure: A mixture of 4a (100 mg, 0.387 mmol), benzylamine 2A (41.5 mg, 0.387 mmol), and [IrCl(cod)]2 (10.4 mg, 0.0155 mmol) in MeCN (1.0 mL) was stirred under argon atmosphere at 20 °C for 2 h. The reaction mixture was concentrated at reduced pressure. Purification of the residue by preparative TLC (hexane:EtOAc = 10:1) afforded cis-9A (43 mg, 52%) and trans-9A (26 mg, 32%). cis-9A: 1H NMR (500 MHz, CDCl3): δ = 7.28-7.19 (5 H, m), 5.70 (2 H, m), 5.13 (2 H, d, J = 17.1 Hz), 5.02 (2 H, d, J = 10.1 Hz), 3.74 (2 H, s), 3.06 (2 H, br m), 1.81 (2 H, br m), 1.58 (2 H, br m). 13C NMR (125 MHz, CDCl3): δ = 141.7, 137.7, 130.0, 127.7, 126.6, 115.6, 66.4, 53.8, 30.4. HRMS: Calcd for C15H19N (M+): 213.1517. Found: 213.1525. trans-9A: 1H NMR (500 MHz, CDCl3):
δ = 7.44-7.10 (5 H, m), 5.78 (2 H, ddd, J = 8.9, 10.1, 17.1 Hz), 5.08 (2 H, d, J = 10.1 Hz), 5.00 (2 H, d, J = 17.1 Hz), 3.80, 3.39 (2 H, AB q, J = 13.7 Hz), 3.39 (2 H, br m), 2.10 (2 H, br m), 1.61 (2 H, br m). 13C NMR (125 MHz, CDCl3): δ = 140.4, 139.7, 128.6, 127.9, 126.3, 116.2, 63.8, 51.2, 30.0. HRMS: Calcd for C15H19N (M+): 213.1517. Found: 213.1510.